31.07.2013 • News

BASF Aims to Top 2013 Figures Despite Weaker H1

The world's largest chemical producer found the going tougher than expected in the first half of 2013. Sales revenue increased by 4% to €8.1 billion, and EBIT before special items by 2.5% to €4 billion, In Q2, sales added 3% year-on-year to just under €18.4 billion, thanks to higher volumes and a strong performance of the Agriculture and Oil & Gas segments. However, EBIT before special items declined 5% to €1.8 billion. Meeting the earnings forecast announced at the beginning of 2013 now appears "significantly more challenging," BASF CEO Kurt Bock said, but stressed that the group still aims to top the 2012 figures. 

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read